Choosing ART: What Does the Evidence Say?

Choosing ART: What Does the Evidence Say? is organized by CME Outfitters, LLC.

Premiere Date: Thursday, October 29, 2020
Credit Expiration Date: Friday, October 29, 2021

Accreditation:
CME Credit (Physicians):
CME Outfitters, LLC, designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs)

ABIM/MOC Credit:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.

Note to PAs: PAs may claim a maximum of .5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Statement of Need:
There have been many recent therapeutic advances in human immunodeficiency virus (HIV), aiming to improve rates of viral suppression, reduce treatment burden, and improve treatment adherence. Current HIV guidelines provide recommendations for managing patients with HIV, including treatment initiation, therapy switching, and individualized treatment regimens for special populations. Rapid antiretroviral therapy (ART) initiation is imperative for early virologic suppression after HIV infection, as it improves health outcomes and decreases transmission. All individuals living with HIV should be offered ART following a confirmed diagnosis, with same-day initiation available. However, despite the benefits of early treatment, ART initiation is often delayed.

This CME Outfitters BriefCase focuses on incorporating the latest evidence-based and guideline-directed treatment strategies for a patient who has been newly diagnosed with HIV.

Learning Objectives:
At the end of this CE activity, participants should be able to:
• Incorporate the latest evidence-based and guideline-directed treatment strategies in the management of patients newly diagnosed with HIV.

The following learning objectives pertain only to those requesting CNE or CPE credit:
• Assess the latest evidence-based and guideline-directed treatment strategies in the management of patients newly diagnosed with HIV.